Comprehensive Patient Care in BRG Clinical Trials

The safety of clinical trial participants is the foundation of our operations. At BRG, comprehensive patient care is not an addition — it is the standard.

Participation in a clinical trial may involve health risks for the patient. Therefore, before the study begins, each patient receives detailed information regarding the course of the study, its potential benefits, and possible adverse events. The decision to participate is always voluntary and made consciously.

 

During the study, the patient:

  • remains under the continuous care of a qualified medical team,

  • has direct contact with the Principal Investigator,

  • is regularly monitored in accordance with the study protocol and applicable standards,

  • may report any concerning symptoms at any time.

We ensure full medical care both during the study and in the event of any health problems occurring after the study. Every patient report is treated with the utmost attention, and appropriate actions are taken immediately in accordance with applicable safety procedures.

Go back

News

Happy Easter from BioResearch Group

On the occasion of Easter, we would like to extend our warmest wishes of peace, joy, and renewed energy

Read more …

Clinical research reshapes nicotine regulation – new publication by BRG CEO

BioResearch Group (BRG) announces the publication of a new article by Dr Katarzyna Jarus-Dziedzic.

Read more …

BRG’s Contribution to the Advancement of an Innovative Therapy

Phase I clinical trials conducted at BRG play a key role in the development of new therapies

Read more …

Comprehensive Patient Care in BRG Clinical Trials

 At BRG, comprehensive patient care is not an addition — it is the standard.

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2026 © Bio Research Group. All rights reserved.

 

scroll to top ▲